Northern Trust’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-11,032
| Closed | -$43.8K | – | 4469 |
|
|
2025
Q3 | $43.8K | Sell |
11,032
-1
| -0% | -$7 | ﹤0.01% | 4297 |
|
|
2025
Q2 | $132K | Hold |
11,033
| – | – | ﹤0.01% | 4046 |
|
|
2025
Q1 | $152K | Hold |
11,033
| – | – | ﹤0.01% | 4015 |
|
|
2024
Q4 | $157K | Buy |
11,033
+2,136
| +24% | +$35.1K | ﹤0.01% | 4053 |
|
|
2024
Q3 | $169K | Hold |
8,897
| – | – | ﹤0.01% | 3930 |
|
|
2024
Q2 | $173K | Sell |
8,897
-5
| -0.1% | -$97 | ﹤0.01% | 3906 |
|
|
2024
Q1 | $204K | Buy |
8,902
+2,784
| +46% | +$60K | ﹤0.01% | 3892 |
|
|
2023
Q4 | $107K | Sell |
6,118
-201
| -3% | -$2.87K | ﹤0.01% | 4101 |
|
|
2023
Q3 | $82.5K | Sell |
6,319
-79
| -1% | -$1.2K | ﹤0.01% | 4056 |
|
|
2023
Q2 | $107K | Sell |
6,398
-27
| -0.4% | -$465 | ﹤0.01% | 4019 |
|
|
2023
Q1 | $100K | Buy |
6,425
+494
| +8% | +$9.59K | ﹤0.01% | 4086 |
|
|
2022
Q4 | $99.6K | Hold |
5,931
| – | – | ﹤0.01% | 4092 |
|
|
2022
Q3 | $101K | Hold |
5,931
| – | – | ﹤0.01% | 4107 |
|
|
2022
Q2 | $131K | Sell |
5,931
-523
| -8% | -$12.7K | ﹤0.01% | 4066 |
|
|
2022
Q1 | $222K | Buy |
6,454
+2
| +0% | +$60 | ﹤0.01% | 4096 |
|
|
2021
Q4 | $266K | Sell |
6,452
-430
| -6% | -$27.9K | ﹤0.01% | 4080 |
|
|
2021
Q3 | $619K | Buy |
6,882
+1,028
| +18% | +$90.7K | ﹤0.01% | 3688 |
|
|
2021
Q2 | $428K | Hold |
5,854
| – | – | ﹤0.01% | 3776 |
|
|
2021
Q1 | $217K | Buy |
5,854
+298
| +5% | +$15K | ﹤0.01% | 4092 |
|
|
2020
Q4 | $228K | Buy |
5,556
+100
| +2% | +$2.59K | ﹤0.01% | 3936 |
|
|
2020
Q3 | $126K | Sell |
5,456
-531
| -9% | -$13.7K | ﹤0.01% | 3911 |
|
|
2020
Q2 | $169K | Buy |
5,987
+64
| +1% | +$1.88K | ﹤0.01% | 3803 |
|
|
2020
Q1 | $151K | Buy |
5,923
+1,328
| +29% | +$49.1K | ﹤0.01% | 3738 |
|
|
2019
Q4 | $200K | Buy |
4,595
+462
| +11% | +$9.71K | ﹤0.01% | 3799 |
|
|
2019
Q3 | $39K | Sell |
4,133
-15,560
| -79% | -$223K | ﹤0.01% | 4076 |
|
|
2019
Q2 | $287K | Sell |
19,693
-1,266
| -6% | -$22.6K | ﹤0.01% | 3709 |
|
|
2019
Q1 | $434K | Sell |
20,959
-80
| -0.4% | -$1.59K | ﹤0.01% | 3577 |
|
|
2018
Q4 | $337K | Sell |
21,039
-57
| -0.3% | -$2.67K | ﹤0.01% | 3642 |
|
|
2018
Q3 | $1.95M | Buy |
21,096
+312
| +2% | +$37.1K | ﹤0.01% | 3229 |
|
|
2018
Q2 | $3.33M | Buy |
20,784
+4,557
| +28% | +$768K | ﹤0.01% | 2931 |
|
|
2018
Q1 | $2.61M | Buy |
16,227
+1,299
| +9% | +$158K | ﹤0.01% | 2968 |
|
|
2017
Q4 | $1.57M | Sell |
14,928
-152
| -1% | -$16.3K | ﹤0.01% | 3259 |
|
|
2017
Q3 | $1.98M | Buy |
15,080
+315
| +2% | +$38.5K | ﹤0.01% | 3183 |
|
|
2017
Q2 | $2.02M | Buy |
14,765
+7,184
| +95% | +$863K | ﹤0.01% | 3161 |
|
|
2017
Q1 | $903K | Buy |
7,581
+1,478
| +24% | +$174K | ﹤0.01% | 3377 |
|
|
2016
Q4 | $818K | Buy |
+6,103
| New | +$1.53M | ﹤0.01% | 3406 |
|
Other funds holding CLSD
Northern Trust's CLSD Position: Q4 2025 in Review
Northern Trust sold out of Clearside Biomedical (CLSD) in Q4 2025, closing a stake of 11,032 shares — an estimated $43.8K sold.
Northern Trust first reported a position in CLSD in Q4 2016 and held it in 36 quarters. The position peaked at $3.33M in Q2 2018. 1 fund tracked by Wall St. Rank holds CLSD as of Q4 2025.
- Northern Trust reported no remaining Clearside Biomedical position as of Q4 2025 after selling out during the quarter.
- Northern Trust sold 11,032 Clearside Biomedical shares in Q4 2025, an estimated $43.8K.
- Northern Trust first reported a position in Clearside Biomedical in Q4 2016 and held it in 36 quarters.
- Northern Trust's Clearside Biomedical position peaked at $3.33M in Q2 2018.
- 1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q4 2025.
Based on Northern Trust's 13F filing for Q4 2025, filed 17 Feb 2026.